(CRJ) Creepy Jar - Ratings and Ratios
Survival Simulator Games, Video Games
CRJ EPS (Earnings per Share)
CRJ Revenue
Description: CRJ Creepy Jar
Creepy Jar S.A. is a Polish video game developer and publisher specializing in survival simulator games. The company, founded in 2016 and headquartered in Warsaw, has gained recognition for titles such as StarRupture and Green Hell, showcasing its capability in the interactive home entertainment sector.
From a financial perspective, Creepy Jars market capitalization stands at 316.11M PLN, indicating a considerable presence in the market. The Price-to-Earnings ratio is 18.69, suggesting that the stock is reasonably valued relative to its earnings. The Return on Equity (RoE) of 16.76% is a positive indicator of the companys ability to generate profits from shareholders equity.
Analyzing the companys stock performance, we observe a significant upward trend, with the stock price at 454.00, above its SMA20 and SMA50 averages, indicating a positive short to medium-term outlook. The stocks position above its SMA200 average further reinforces the long-term bullish sentiment. The Average True Range (ATR) of 18.00, or 3.96%, suggests moderate volatility, which is a characteristic of the stock markets reaction to the companys performance and industry trends.
To further evaluate Creepy Jars potential, we can examine additional KPIs such as the Price-to-Book (P/B) ratio, Debt-to-Equity ratio, and revenue growth rate. A lower P/B ratio could indicate undervaluation, while a healthy Debt-to-Equity ratio would suggest financial stability. Revenue growth rate would provide insights into the companys ability to expand its operations and increase profitability.
Considering the gaming industrys growth prospects and Creepy Jars niche in survival simulator games, the companys future outlook appears promising. The success of its current titles and the potential for new releases could drive further growth. Investors should, however, remain cautious and monitor industry trends, the companys financial health, and competitive landscape to make informed decisions.
CRJ Stock Overview
| Market Cap in USD | 85m |
| Sub-Industry | Interactive Home Entertainment |
| IPO / Inception |
CRJ Stock Ratings
| Growth Rating | -24.2% |
| Fundamental | 62.9% |
| Dividend Rating | 0.38% |
| Return 12m vs S&P 500 | -16.1% |
| Analyst Rating | - |
CRJ Dividends
| Dividend Yield 12m | 2.76% |
| Yield on Cost 5y | 1.11% |
| Annual Growth 5y | -15.20% |
| Payout Consistency | 82.8% |
| Payout Ratio | 54.6% |
CRJ Growth Ratios
| Growth Correlation 3m | 67.9% |
| Growth Correlation 12m | 48% |
| Growth Correlation 5y | -80.3% |
| CAGR 5y | -14.93% |
| CAGR/Max DD 5y | -0.19 |
| Sharpe Ratio 12m | -1.57 |
| Alpha | -11.57 |
| Beta | 0.490 |
| Volatility | 36.54% |
| Current Volume | 0.3k |
| Average Volume 20d | 0.8k |
| Stop Loss | 435.2 (-5.2%) |
| Signal | -2.06 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (17.6m TTM) > 0 and > 6% of Revenue (6% = 1.93m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -0.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 240.1% (prev 238.8%; Δ 1.28pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 20.6m > Net Income 17.6m (YES >=105%, WARN >=100%) |
| error: Net Debt/EBITDA cannot be calculated |
| Current Ratio 18.23 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (699.4k) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 99.01% (prev 99.13%; Δ -0.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 28.61% (prev 30.73%; Δ -2.12pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 196.2 (EBITDA TTM 17.7m / Interest Expense TTM 90.1k) >= 6 (WARN >= 3) |
Altman Z'' 9.89
| (A) 0.65 = (Total Current Assets 81.9m - Total Current Liabilities 4.49m) / Total Assets 118.8m |
| (B) 0.18 = Retained Earnings (Balance) 20.9m / Total Assets 118.8m |
| (C) 0.16 = EBIT TTM 17.7m / Avg Total Assets 112.7m |
| (D) 3.79 = Book Value of Equity 20.9m / Total Liabilities 5.51m |
| Total Rating: 9.89 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.88
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 2.90% = 1.45 |
| 3. FCF Margin 24.87% = 6.22 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC 14.98% = 12.50 |
| 7. RoE 16.76% = 1.40 |
| 8. Rev. Trend -82.15% = -4.11 |
| 9. Rev. CAGR -22.27% = -2.50 |
| 10. EPS Trend -23.51% = -0.59 |
| 11. EPS CAGR 0.08% = 0.01 |
What is the price of CRJ shares?
Over the past week, the price has changed by -4.38%, over one month by -8.02%, over three months by +11.40% and over the past year by -1.83%.
Is Creepy Jar a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRJ is around 411.77 PLN . This means that CRJ is currently overvalued and has a potential downside of -10.29%.
Is CRJ a buy, sell or hold?
What are the forecasts/targets for the CRJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 458 | -0.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 456.3 | -0.6% |
CRJ Fundamental Data Overview
Market Cap PLN = 311.9m (311.9m PLN * 1.0 PLN.PLN)
CCE Cash And Equivalents = 35.4m PLN (Cash only, last quarter)
P/E Trailing = 18.4526
P/S = 9.6737
P/B = 2.7541
Beta = 0.751
Revenue TTM = 32.2m PLN
EBIT TTM = 17.7m PLN
EBITDA TTM = 17.7m PLN
Long Term Debt = unknown (0.0)
Short Term Debt = unknown (0.0)
Debt = unknown
Net Debt = unknown
Enterprise Value = 276.5m PLN (311.9m + (null Debt) - CCE 35.4m)
Interest Coverage Ratio = 196.2 (Ebit TTM 17.7m / Interest Expense TTM 90.1k)
FCF Yield = 2.90% (FCF TTM 8.02m / Enterprise Value 276.5m)
FCF Margin = 24.87% (FCF TTM 8.02m / Revenue TTM 32.2m)
Net Margin = 54.52% (Net Income TTM 17.6m / Revenue TTM 32.2m)
Gross Margin = 99.01% ((Revenue TTM 32.2m - Cost of Revenue TTM 317.6k) / Revenue TTM)
Tobins Q-Ratio = 13.23 (Enterprise Value 276.5m / Book Value Of Equity 20.9m)
Interest Expense / Debt = unknown (Interest Expense 21.5k / Debt none)
Taxrate = 11.07% (from yearly Tax Provision: 1.98m / 17.9m)
NOPAT = 15.7m (EBIT 17.7m * (1 - 11.07%))
Current Ratio = 18.23 (Total Current Assets 81.9m / Total Current Liabilities 4.49m)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 17.7m)
Debt / FCF = none (Debt none / FCF TTM 8.02m)
Total Stockholder Equity = 104.9m (last 4 quarters mean)
RoA = 14.80% (Net Income 17.6m, Total Assets 118.8m )
RoE = 16.76% (Net Income TTM 17.6m / Total Stockholder Equity 104.9m)
RoCE = 16.85% (Ebit 17.7m / (Equity 104.9m + L.T.Debt 0.0))
RoIC = 14.98% (NOPAT 15.7m / Invested Capital 104.9m)
WACC = unknown (E(311.9m)/V(0.0) * Re(7.82%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(0.11)))
Discount Rate = 7.82% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 78.83% ; FCFE base≈7.89m ; Y1≈8.20m ; Y5≈9.38m
Fair Price DCF = 235.7 (DCF Value 164.9m / Shares Outstanding 699.4k; 5y FCF grow 4.04% → 3.0% )
Revenue Correlation: -82.15 | Revenue CAGR: -22.27%
Rev Growth-of-Growth: 45.49
EPS Correlation: -23.51 | EPS CAGR: 0.08%
EPS Growth-of-Growth: 103.6